TOKYO -- Japanese pharmaceutical company Daiichi Sankyo is in discussions to secure Japan supplies of a potential coronavirus vaccine being developed by British pharmaceutical giant AstraZeneca and Oxford University.
Daiichi Sankyo to distribute doses if UK development is successful
AstraZeneca aims to supply Japan with a vaccine in cooperation with its group companies, Daiichi Sankyo and Meiji Holdings. © Reuters
TOKYO -- Japanese pharmaceutical company Daiichi Sankyo is in discussions to secure Japan supplies of a potential coronavirus vaccine being developed by British pharmaceutical giant AstraZeneca and Oxford University.